Friday 15 November 2024

The Pharma Letter Podcast — Episode 13 — Is there a data capture crisis in biotech?

Biotechnology
Simon Wentworth
5 April 2022
thepharmaletterpodcast-episode13-1

More on this story...

Biotechnology
The Pharma Letter Podcast — Episode 12 — Mastering the microbiome
9 March 2022
Biotechnology
The Pharma Letter Podcast — Episode 9 — The rise of AI in drug discovery
30 December 2021
Pharmaceutical
The Pharma Letter Podcast — Episode 10 — Will decentralized clinical trials become the new standard?
10 February 2022
Biotechnology
Major entrant in biotech discovery could shake up existing order
6 May 2022


More ones to watch >


Today's issue

Former Mirati CMO Alan Sandler joins ALX Oncology
Biotechnology
Former Mirati CMO Alan Sandler joins ALX Oncology
14 November 2024
Biotechnology
Merck & Co wades into PD-1/VEGF space via deal with LaNova Medicines
14 November 2024
Pharmaceutical
Positive results for Microbion’s new diabetic foot ulcer drug
14 November 2024
Pharmaceutical
ARTBIO inks exclusive deal with 3BP to grow radioligand pipeline
14 November 2024
Pharmaceutical
Momentum flagging, a Phase III data win spurs tirzepatide
14 November 2024
Pharmaceutical
Merck KGaA shares slip on cautious outlook
14 November 2024
Biotechnology
AC Immune Phase II ACI-7104.056 success in Parkinson’s
14 November 2024

Company Spotlight

A biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.




More Features in Biotechnology

Former Mirati CMO Alan Sandler joins ALX Oncology
14 November 2024
Merck & Co wades into PD-1/VEGF space via deal with LaNova Medicines
14 November 2024
AC Immune Phase II ACI-7104.056 success in Parkinson’s
14 November 2024
The Pharma Letter Podcast — Episode 29 — How can we use AI to program antibodies?
14 November 2024


Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze